Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Method and apparatus for planning base station controllers in a wireless network
Image forming apparatus and method for controlling the same
Flip-flop circuit, frequency divider and frequency dividing method
Method of making a semiconductor structure useful in making a split gate non-volatile memory cell
Mobile station apparatus, communication system and communication method
Automatic allocation of data replicas
Apparatus for releasing magnetic security device
  Randomly Featured Patents
Method of elliptic curve cryptographic digital signature generation and verification using reduced base tau expansion in non-adjacent form
Process for the preparation of silica spheres
System and method for detecting radiological waste by trash collection vehicles
Process for trimerization
Variable compression ratio apparatus
Match resolution circuit for an associative memory
Check valve with pressure relief feature
High efficiency translation of mRNA molecules
Cutting apparatus
Protection system for part molding machines